Mehrdad Rezaee, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 10 carriers
- Offices
- 2
- Since medical school
- 32 years
- Medical College of Wisconsin, 1994
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
36 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rezaee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G83930 · Current
Licensed to practise in California · since 1997 · expires 2028-10-31 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$392,701
Medicare paid this office $392,701 for 518 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 63 | $99,450 | $1,554 |
| Return visit (30+ min) | 285 | $61,058 | $111 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 63 | $52,201 | $408 |
| Long return visit (40+ min) | 122 | $38,332 | $155 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 40 | $37,657 | $897 |
See all 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 63 | $99,450 | $1,554 |
| Return visit (30+ min) | 285 | $61,058 | $111 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 63 | $52,201 | $408 |
| Long return visit (40+ min) | 122 | $38,332 | $155 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 40 | $37,657 | $897 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $21,789 | $189 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $8,889 | $468 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,347 | $155 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 74 | $5,511 | $71 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 29 | $4,553 | $152 |
| Programming of dual lead pacemaker system | 46 | $4,212 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $4,152 | $61 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $3,410 | $201 |
| Injection of drug or substance into vein | 66 | $2,612 | $39 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 40 | $2,529 | $60 |
| New patient visit (45+ min) | 15 | $2,150 | $143 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 36 | $2,097 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 36 | $1,891 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 40 | $950 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 62 | $940 | $13 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 45 | $883 | None |
| Infusion, normal saline solution, 250 cc | 66 | $272 | None |
| Injection, regadenoson, 0.1 mg | 19 | $170 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 52 | More than 83% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
| Varicose vein removal | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 15 | – | – | – | – | – |
| Insertion of permanent leadless pacemaker using imaging guidance | – | – | – | 11 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
518 Original Medicare patients in 2024. Average age 79 · Under 65 4% · 85 and older 28% · Women 50% · Also on Medicaid 35% · Health risk score 1.71. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 65% · Diabetes 48% · Chronic kidney disease 34% · Atrial fibrillation 33% · Heart failure 29% · Depression 19% · COPD 17% · Cancer 14% · Dementia 14% · Stroke 13%.
The office billed $1,552,049, Medicare allowed $513,764 and paid $392,701; for 4,645 services of 58 kinds; $1,335 of it was for drugs given in the office and $391,366 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 518 | 4,645 | 79 | 1.71 | $1,552,049 | $392,701 |
| 2023 | 636 | 5,346 | 78 | 1.73 | $1,572,349 | $388,988 |
| 2022 | 624 | 6,235 | 78 | 1.82 | $1,789,363 | $461,388 |
| 2021 | 569 | 6,356 | 78 | 1.76 | $1,647,671 | $439,214 |
| 2020 | 566 | 5,030 | 78 | 1.70 | $1,324,537 | $390,014 |
| 2019 | 710 | 8,192 | 78 | 1.82 | $1,042,450 | $514,906 |
| 2018 | 621 | 8,510 | 78 | 1.68 | $883,947 | $414,959 |
| 2017 | 695 | 7,391 | 78 | 1.69 | $923,019 | $389,285 |
| 2016 | 628 | 3,039 | 78 | 1.59 | $532,217 | $228,341 |
| 2015 | 600 | 2,725 | 78 | 1.51 | $580,445 | $268,749 |
| 2014 | 701 | 3,370 | 78 | 1.42 | $751,414 | $341,699 |
| 2013 | 621 | 3,028 | 77 | 1.56 | $794,677 | $329,963 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 58 | $90,138 | $1,554 |
| Return visit (30+ min) | 299 | $60,342 | $111 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 58 | $46,631 | $402 |
| Long return visit (40+ min) | 118 | $38,400 | $159 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 38 | $36,523 | $936 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 124 | $25,025 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $11,375 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $8,601 | $156 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $8,293 | $436 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $4,622 | $70 |
| New patient visit (45+ min) | 29 | $4,379 | $151 |
| Programming of dual lead pacemaker system | 42 | $4,216 | $70 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $3,782 | $164 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 19 | $3,629 | $191 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 41 | $3,042 | $71 |
| New patient visit (60+ min) | 13 | $2,693 | $207 |
| Injection of drug or substance into vein | 61 | $2,413 | $40 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 38 | $2,282 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 39 | $2,193 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,716 | $107 |
| Short return visit (20+ min) | 16 | $1,408 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 88 | $1,245 | $13 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 55 | $1,052 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 38 | $900 | $23 |
| Infusion, normal saline solution, 250 cc | 62 | $241 | None |
2022: 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 75 | $118,130 | $1,575 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 75 | $61,604 | $411 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 53 | $55,739 | $995 |
| Return visit (30+ min) | 269 | $55,342 | $109 |
| Long return visit (40+ min) | 138 | $47,300 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $29,158 | $201 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $12,072 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $11,068 | $179 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,994 | $500 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $6,989 | $194 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 76 | $5,435 | $72 |
| Programming of dual lead pacemaker system | 39 | $4,280 | $75 |
| Insertion of permanent leadless pacemaker using imaging guidance | 11 | $4,110 | $374 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 54 | $4,060 | $70 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 20 | $3,081 | $154 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 37 | $2,029 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 39 | $1,982 | $21 |
| Injection of drug or substance into vein | 47 | $1,959 | $42 |
| New patient visit (45+ min) | 14 | $1,836 | $131 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 53 | $1,323 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 76 | $1,207 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 69 | $912 | $12 |
| Infusion, normal saline solution, 250 cc | 76 | $319 | None |
2021: 24 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 72 | $118,143 | $1,641 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 72 | $60,356 | $419 |
| Return visit (30+ min) | 278 | $55,432 | $116 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 49 | $38,824 | $792 |
| Long return visit (40+ min) | 144 | $38,712 | $157 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $25,804 | $210 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,211 | $184 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,702 | $513 |
| Programming of dual lead pacemaker system | 55 | $7,083 | $71 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $6,243 | $66 |
| New patient visit (45+ min) | 40 | $6,145 | $154 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 81 | $5,794 | $72 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 29 | $5,770 | $199 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 61 | $4,674 | $77 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 23 | $3,697 | $161 |
| New patient visit (60+ min) | 18 | $3,651 | $203 |
| Short return visit (20+ min) | 33 | $2,741 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,495 | $125 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 32 | $1,851 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 117 | $1,654 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,610 | $27 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 75 | $1,576 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 49 | $1,168 | $24 |
| Infusion, normal saline solution, 250 cc | 81 | $357 | None |
2020: 28 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 41 | $66,010 | $1,610 |
| Long return visit (40+ min) | 199 | $50,648 | $130 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 50 | $40,806 | $785 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 41 | $33,443 | $408 |
| Return visit (30+ min) | 217 | $31,554 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $28,177 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $15,456 | $186 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $9,424 | $524 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $8,224 | $514 |
| Programming of dual lead pacemaker system | 50 | $6,492 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $5,164 | $68 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 31 | $5,036 | $157 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 24 | $4,937 | $206 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 53 | $4,870 | $84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 60 | $4,152 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | $3,133 | $98 |
| New patient visit (60+ min) | 17 | $3,126 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,873 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 147 | $2,508 | $16 |
| New patient visit (45+ min) | 16 | $2,303 | $144 |
| Short return visit (20+ min) | 35 | $2,151 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,151 | $127 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 51 | $1,300 | $25 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 53 | $1,130 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 17 | $654 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $496 | $29 |
| Infusion, normal saline solution, 250 cc | 57 | $228 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $222 | $18 |
2019: 29 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 70 | $108,926 | $1,556 |
| Long return visit (40+ min) | 218 | $63,140 | $130 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 68 | $56,196 | $413 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 64 | $55,058 | $765 |
| Return visit (30+ min) | 267 | $42,572 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 158 | $34,573 | $195 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 12 | $22,444 | $1,496 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $21,600 | $183 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $10,260 | $513 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 115 | $8,104 | $68 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 31 | $6,801 | $206 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 90 | $6,428 | $69 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 71 | $6,269 | $80 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $5,982 | $498 |
| Programming of dual lead pacemaker system | 60 | $5,293 | $53 |
| Short return visit (20+ min) | 67 | $5,189 | $67 |
| Critical care, first 30-74 minutes | 22 | $5,136 | $198 |
| New patient visit (60+ min) | 28 | $4,908 | $175 |
| New patient visit (45+ min) | 28 | $4,027 | $144 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 74 | $2,757 | None |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $2,356 | $196 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | $2,318 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 44 | $2,168 | $44 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $2,048 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 120 | $1,988 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 63 | $1,689 | $23 |
| Blood test, clotting time | 13 | $355 | $4 |
| Infusion, normal saline solution, 250 cc | 81 | $315 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $62 | $4 |
2018: 29 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 64 | $97,313 | $1,521 |
| Return visit (30+ min) | 329 | $59,471 | $89 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 64 | $47,958 | $381 |
| Long return visit (40+ min) | 144 | $31,803 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $31,309 | $190 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $15,385 | $481 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 15 | $11,858 | $741 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,595 | $168 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 38 | $7,704 | $188 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 109 | $7,491 | $62 |
| Short return visit (20+ min) | 88 | $7,296 | $58 |
| Programming of dual lead pacemaker system | 74 | $7,225 | $48 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 13 | $6,938 | $534 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 28 | $5,209 | $90 |
| New patient visit (60+ min) | 29 | $4,799 | $165 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 48 | $4,201 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $4,140 | $63 |
| New patient visit (45+ min) | 26 | $3,089 | $119 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 78 | $3,027 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $2,309 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 96 | $1,389 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,322 | $88 |
| New patient visit (30+ min) | 12 | $765 | $64 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $575 | $22 |
| Blood test, clotting time | 18 | $551 | $5 |
| External ekg recording for more than 48 hours up to 21 days | 16 | $447 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 15 | $369 | $23 |
| Infusion, normal saline solution, 250 cc | 94 | $352 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $222 | $7 |
2017: 27 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 46 | $66,721 | $1,450 |
| Return visit (30+ min) | 342 | $57,386 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $36,876 | $212 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 49 | $24,265 | $467 |
| Long return visit (40+ min) | 117 | $19,783 | $114 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 45 | $18,866 | $214 |
| Short return visit (20+ min) | 190 | $17,886 | $60 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 67 | $13,217 | $186 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $11,220 | $167 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 17 | $9,528 | $529 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 49 | $9,109 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 97 | $6,576 | $64 |
| Programming of dual lead pacemaker system | 68 | $6,179 | $48 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $5,147 | $53 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $5,000 | $179 |
| New patient visit (60+ min) | 25 | $4,225 | $169 |
| Critical care, first 30-74 minutes | 13 | $3,474 | $183 |
| New patient visit (45+ min) | 29 | $3,358 | $116 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $2,499 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,476 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 160 | $2,375 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,003 | $87 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 69 | $1,802 | None |
| New patient visit (30+ min) | 13 | $1,079 | $83 |
| Blood test, clotting time | 20 | $766 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 70 | $762 | $10 |
| Infusion, normal saline solution, 250 cc | 55 | $179 | None |
2016: 25 services
| Return visit (30+ min) | 325 | $47,278 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $25,920 | $206 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 45 | $20,942 | $465 |
| Short return visit (20+ min) | 175 | $14,483 | $59 |
| Long return visit (40+ min) | 81 | $13,569 | $120 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 45 | $7,839 | $89 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 12 | $7,142 | $549 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | $6,022 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,480 | $171 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $4,973 | $199 |
| New patient visit (45+ min) | 37 | $4,609 | $125 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $3,664 | $17 |
| New patient visit (60+ min) | 22 | $3,550 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,973 | $114 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 40 | $2,778 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 148 | $2,392 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $2,349 | $53 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 11 | $2,064 | $188 |
| Programming of dual lead pacemaker system | 40 | $1,741 | $41 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,602 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 43 | $1,231 | $29 |
| Blood test, clotting time | 39 | $1,208 | $5 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 43 | $1,143 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $404 | $34 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 16 | $302 | None |
2015: 25 services
| Return visit (30+ min) | 326 | $47,178 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 156 | $31,687 | $197 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 68 | $29,317 | $431 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 11 | $27,725 | $1,386 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 68 | $16,891 | $125 |
| Long return visit (40+ min) | 60 | $12,400 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,240 | $172 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 12 | $6,867 | $528 |
| Short return visit (20+ min) | 75 | $5,630 | $62 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 43 | $4,955 | $17 |
| Programming of dual lead pacemaker system | 58 | $4,779 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $4,772 | $65 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 26 | $4,674 | $180 |
| New patient visit (45+ min) | 29 | $3,954 | $136 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,873 | $242 |
| New patient visit (60+ min) | 20 | $3,496 | $175 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $3,345 | $209 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,226 | $52 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 68 | $2,198 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 137 | $2,149 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 28 | $2,142 | $77 |
| Blood test, clotting time | 44 | $1,582 | $5 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,060 | $88 |
| Short return visit | 19 | $821 | $39 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 48 | $32 | None |
2014: 24 services
| Return visit (30+ min) | 325 | $50,138 | $82 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 110 | $49,478 | $450 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 205 | $43,183 | $202 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 110 | $26,824 | $122 |
| Long return visit (40+ min) | 74 | $18,001 | $119 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $13,719 | $443 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $12,624 | $168 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 50 | $10,340 | $203 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 125 | $7,573 | $60 |
| Programming of dual lead pacemaker system | 81 | $7,331 | $44 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 37 | $6,783 | $178 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $5,284 | $17 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 110 | $3,482 | $16 |
| New patient visit (45+ min) | 27 | $2,871 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,783 | $58 |
| New patient visit (60+ min) | 15 | $2,545 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,486 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 46 | $2,426 | $53 |
| Short return visit (20+ min) | 41 | $2,003 | $47 |
| Blood test, clotting time | 47 | $1,978 | $5 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $1,835 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 106 | $1,685 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,070 | $89 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 58 | $126 | None |
2013: 29 services
| Return visit (30+ min) | 302 | $46,950 | $84 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 19 | $45,017 | $1,731 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 83 | $40,711 | $485 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 129 | $22,241 | $166 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 83 | $20,945 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $14,608 | $166 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $14,551 | $346 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 48 | $13,013 | $237 |
| Long return visit (40+ min) | 60 | $12,101 | $123 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 36 | $6,833 | $180 |
| Programming of dual lead pacemaker system | 72 | $6,100 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 94 | $5,992 | $62 |
| Short return visit (20+ min) | 108 | $5,437 | $42 |
| New patient visit (45+ min) | 37 | $4,587 | $124 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $4,337 | $17 |
| Balloon dilation of single coronary artery or branch | 11 | $4,161 | $320 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,151 | $59 |
| Critical care, first 30-74 minutes | 20 | $3,624 | $181 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $3,509 | $251 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 36 | $3,193 | None |
| New patient visit (60+ min) | 18 | $2,900 | $161 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 83 | $2,748 | $16 |
| Insertion of tube in right and left heart chambers for diagnosis with review by radiologist | 11 | $2,672 | $223 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $2,454 | $79 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $2,156 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 127 | $2,110 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,955 | $85 |
| Blood test, clotting time | 45 | $1,772 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 31 | $1,634 | $53 |
Medicaid work
$11,293 in 2024
Medicaid paid $11,293 for 1,218 billed services this clinician did in 2024, up to 172 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 327 | $6,589 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 879 | $4,046 |
| Return visit (30+ min) | 12 | $658 |
| 2024 | 1,218 | 3 | 172 | $11,293 |
| 2023 | 1,534 | 2 | 146 | $11,357 |
| 2022 | 967 | 2 | 120 | $13,574 |
| 2021 | 731 | 2 | 116 | $7,698 |
| 2020 | 258 | 1 | 90 | $1,354 |
| 2019 | 79 | 1 | 63 | $399 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 408 | $7,013 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,126 | $4,344 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 408 | $10,147 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 559 | $3,427 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 147 | $4,188 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 584 | $3,511 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 258 | $1,354 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 79 | $399 |
Drugs they prescribed that Part D paid
$676,067
Pharmacies billed $676,067 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,053) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,559 generic and 494 brand-name prescriptions · $676,067 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 275 | $370,407 | $1,347 |
| Entresto | 90 | $128,272 | $1,425 |
| Xarelto | 45 | $60,702 | $1,349 |
| Repatha Sureclick | 24 | $20,929 | $872 |
| Multaq | 13 | $20,333 | $1,564 |
See all 42 drugs
| Eliquis | 275 | $370,407 | $1,347 |
| Entresto | 90 | $128,272 | $1,425 |
| Xarelto | 45 | $60,702 | $1,349 |
| Repatha Sureclick | 24 | $20,929 | $872 |
| Multaq | 13 | $20,333 | $1,564 |
| Rosuvastatin | 203 | $3,767 | $19 |
| Nebivolol | 53 | $3,674 | $69 |
| Metoprolol | 268 | $3,183 | $12 |
| Losartan | 222 | $2,878 | $13 |
| Clopidogrel | 199 | $2,765 | $14 |
| Ezetimibe | 42 | $1,860 | $44 |
| Amiodarone | 32 | $1,624 | $51 |
| Atorvastatin | 164 | $1,413 | $9 |
| Amlodipine Besylate | 173 | $1,389 | $8 |
| Sotalol | 72 | $1,371 | $19 |
| Midodrine | 12 | $1,265 | $105 |
| Diltiazem 24hr Er (Cd) | 35 | $1,023 | $29 |
| Propafenone | 21 | $1,001 | $48 |
| Losartan-Hydrochlorothiazide | 71 | $970 | $14 |
| Digoxin | 48 | $957 | $20 |
| Bumetanide | 31 | $914 | $29 |
| Nifedipine Er | 26 | $836 | $32 |
| Lisinopril | 102 | $696 | $7 |
| Bisoprolol | 16 | $576 | $36 |
| Hydrochlorothiazide | 113 | $538 | $5 |
| Pravastatin | 41 | $523 | $13 |
| Metoprolol | 73 | $467 | $6 |
| Hydralazine | 37 | $424 | $11 |
| Carvedilol | 66 | $373 | $6 |
| Potassium Chloride | 20 | $368 | $18 |
| Valsartan | 13 | $355 | $27 |
| Simvastatin | 29 | $294 | $10 |
| Isosorbide Mononitrate Er | 18 | $292 | $16 |
| Warfarin | 27 | $277 | $10 |
| Furosemide | 65 | $255 | $4 |
| Enalapril Maleate | 13 | $216 | $17 |
| Valsartan-Hydrochlorothiazide | 12 | $183 | $15 |
| Metolazone | 14 | $165 | $12 |
| Spironolactone | 32 | $140 | $4 |
| Ramipril | 11 | $126 | $11 |
| Clonidine | 31 | $86 | $3 |
| Atenolol | 17 | $48 | $3 |
Year by year
| 2024 | 3,053 | 448 | 0% (0) | 16% | $676,067 |
| 2023 | 2,985 | 424 | 0% (0) | 16% | $686,697 |
| 2022 | 3,076 | 428 | 0% (0) | 16% | $690,820 |
| 2021 | 3,288 | 455 | 0% (0) | 17% | $743,849 |
| 2020 | 3,395 | 435 | 0% (0) | 20% | $920,710 |
| 2019 | 3,441 | 457 | 0% (0) | 20% | $818,453 |
| 2018 | 3,495 | 448 | 0% (0) | 20% | $763,510 |
| 2017 | 3,677 | 445 | 0% (0) | 20% | $619,516 |
| 2016 | 3,332 | 380 | 0% (0) | 24% | $583,283 |
| 2015 | 2,986 | 332 | 0% (0) | 23% | $438,879 |
| 2014 | 3,225 | 346 | None | 23% | $383,382 |
| 2013 | 3,330 | 336 | None | None | $344,325 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Eliquis | 284 | $358,041 | $1,261 |
| Entresto | 69 | $93,340 | $1,353 |
| Xarelto | 31 | $51,579 | $1,664 |
| Repatha Sureclick | 26 | $15,348 | $590 |
| Metoprolol | 226 | $4,870 | $22 |
| Nebivolol | 41 | $4,855 | $118 |
| Losartan | 189 | $4,556 | $24 |
| Rosuvastatin | 186 | $4,457 | $24 |
| Icosapent Ethyl | 11 | $4,318 | $393 |
| Clopidogrel | 182 | $3,585 | $20 |
| Diltiazem 24hr Er (Cd) | 56 | $3,218 | $57 |
| Atorvastatin | 143 | $2,339 | $16 |
| Nifedipine Er | 27 | $2,217 | $82 |
| Amiodarone | 40 | $2,193 | $55 |
| Digoxin | 58 | $2,061 | $36 |
| Amlodipine Besylate | 175 | $1,970 | $11 |
| Ezetimibe | 50 | $1,858 | $37 |
| Metolazone | 31 | $1,852 | $60 |
| Losartan-Hydrochlorothiazide | 64 | $1,803 | $28 |
| Bumetanide | 34 | $1,488 | $44 |
| Sotalol | 58 | $1,457 | $25 |
| Midodrine | 15 | $1,222 | $81 |
| Valsartan | 14 | $981 | $70 |
| Carvedilol | 69 | $895 | $13 |
| Bisoprolol | 15 | $879 | $59 |
| Potassium Chloride | 30 | $873 | $29 |
| Lisinopril | 81 | $856 | $11 |
| Hydrochlorothiazide | 137 | $851 | $6 |
| Hydralazine | 36 | $745 | $21 |
| Metoprolol | 74 | $674 | $9 |
| Propafenone | 20 | $663 | $33 |
| Pravastatin | 47 | $609 | $13 |
| Enalapril Maleate | 16 | $489 | $31 |
| Simvastatin | 49 | $444 | $9 |
| Isosorbide Mononitrate Er | 17 | $425 | $25 |
| Spironolactone | 36 | $389 | $11 |
| Warfarin | 19 | $353 | $19 |
| Furosemide | 71 | $311 | $4 |
| Clonidine | 23 | $211 | $9 |
| Atenolol | 16 | $209 | $13 |
| Triamterene-Hydrochlorothiazid | 12 | $119 | $10 |
2022: 44 drugs
| Eliquis | 282 | $321,025 | $1,138 |
| Opsumit | 11 | $142,288 | $12,935 |
| Entresto | 64 | $61,586 | $962 |
| Xarelto | 37 | $55,716 | $1,506 |
| Rosuvastatin | 183 | $7,147 | $39 |
| Bystolic | 12 | $5,117 | $426 |
| Vascepa | 13 | $5,106 | $393 |
| Clopidogrel | 200 | $4,320 | $22 |
| Metoprolol | 220 | $4,179 | $19 |
| Nebivolol | 31 | $4,020 | $130 |
| Amiodarone | 46 | $3,515 | $76 |
| Diltiazem 24hr Er (Cd) | 70 | $3,034 | $43 |
| Digoxin | 67 | $2,611 | $39 |
| Nifedipine Er | 35 | $2,545 | $73 |
| Losartan | 182 | $2,504 | $14 |
| Ezetimibe | 50 | $2,364 | $47 |
| Valsartan | 22 | $2,302 | $105 |
| Atorvastatin | 153 | $2,268 | $15 |
| Losartan-Hydrochlorothiazide | 63 | $2,149 | $34 |
| Bumetanide | 30 | $1,791 | $60 |
| Amlodipine Besylate | 187 | $1,675 | $9 |
| Metolazone | 24 | $1,652 | $69 |
| Sotalol | 65 | $1,628 | $25 |
| Potassium Chloride | 39 | $1,267 | $32 |
| Carvedilol | 66 | $953 | $14 |
| Propafenone | 13 | $949 | $73 |
| Hydrochlorothiazide | 138 | $825 | $6 |
| Lisinopril | 100 | $773 | $8 |
| Hydralazine | 34 | $710 | $21 |
| Pravastatin | 40 | $665 | $17 |
| Dilt-Xr | 11 | $657 | $60 |
| Metoprolol | 79 | $630 | $8 |
| Furosemide | 85 | $515 | $6 |
| Enalapril Maleate | 16 | $500 | $31 |
| Spironolactone | 34 | $433 | $13 |
| Simvastatin | 65 | $424 | $7 |
| Warfarin | 27 | $423 | $16 |
| Isosorbide Mononitrate Er | 21 | $298 | $14 |
| Benazepril | 14 | $214 | $15 |
| Bisoprolol | 13 | $199 | $15 |
| Lisinopril-Hydrochlorothiazide | 12 | $129 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $117 | $10 |
| Atenolol | 11 | $76 | $7 |
| Lovastatin | 12 | $65 | $5 |
2021: 42 drugs
| Eliquis | 263 | $273,619 | $1,040 |
| Opsumit | 11 | $134,489 | $12,226 |
| Entresto | 64 | $65,085 | $1,017 |
| Xarelto | 45 | $56,833 | $1,263 |
| Bystolic | 51 | $20,376 | $400 |
| Rosuvastatin | 192 | $7,154 | $37 |
| Vascepa | 13 | $6,225 | $479 |
| Nifedipine Er | 64 | $4,476 | $70 |
| Metoprolol | 215 | $4,451 | $21 |
| Amiodarone | 50 | $4,214 | $84 |
| Digoxin | 65 | $2,890 | $44 |
| Diltiazem 24hr Er (Cd) | 85 | $2,845 | $33 |
| Clopidogrel | 181 | $2,781 | $15 |
| Losartan | 177 | $2,463 | $14 |
| Atorvastatin | 171 | $2,182 | $13 |
| Valsartan | 15 | $2,100 | $140 |
| Bumetanide | 37 | $2,016 | $54 |
| Ezetimibe | 38 | $2,003 | $53 |
| Amlodipine Besylate | 187 | $1,694 | $9 |
| Propafenone | 19 | $1,581 | $83 |
| Losartan-Hydrochlorothiazide | 66 | $1,468 | $22 |
| Sotalol | 48 | $1,395 | $29 |
| Hydralazine | 52 | $1,252 | $24 |
| Hydrochlorothiazide | 155 | $1,119 | $7 |
| Lisinopril | 136 | $1,045 | $8 |
| Nitroglycerin | 12 | $1,044 | $87 |
| Carvedilol | 82 | $998 | $12 |
| Dilt-Xr | 16 | $950 | $59 |
| Potassium Chloride | 38 | $821 | $22 |
| Warfarin | 40 | $711 | $18 |
| Pravastatin | 32 | $650 | $20 |
| Metoprolol | 91 | $619 | $7 |
| Furosemide | 95 | $510 | $5 |
| Enalapril Maleate | 20 | $506 | $25 |
| Simvastatin | 61 | $437 | $7 |
| Spironolactone | 48 | $386 | $8 |
| Isosorbide Mononitrate Er | 29 | $349 | $12 |
| Benazepril | 15 | $225 | $15 |
| Atenolol | 20 | $152 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $137 | $11 |
| Clonidine | 22 | $98 | $4 |
| Lisinopril-Hydrochlorothiazide | 11 | $96 | $9 |
2020: 44 drugs
| Adempas | 24 | $269,994 | $11,250 |
| Eliquis | 249 | $222,143 | $892 |
| Xarelto | 61 | $72,516 | $1,189 |
| Entresto | 73 | $61,674 | $845 |
| Bystolic | 84 | $28,862 | $344 |
| Brilinta | 24 | $15,228 | $635 |
| Rosuvastatin | 199 | $9,885 | $50 |
| Amiodarone | 77 | $6,694 | $87 |
| Metoprolol | 204 | $5,115 | $25 |
| Digoxin | 80 | $3,986 | $50 |
| Nifedipine Er | 46 | $3,836 | $83 |
| Clopidogrel | 202 | $3,118 | $15 |
| Atorvastatin | 202 | $2,950 | $15 |
| Losartan | 200 | $2,825 | $14 |
| Ranolazine Er | 20 | $2,661 | $133 |
| Diltiazem 24hr Er (Cd) | 52 | $2,473 | $48 |
| Ezetimibe | 42 | $2,408 | $57 |
| Propafenone | 18 | $2,107 | $117 |
| Sotalol | 45 | $1,661 | $37 |
| Bumetanide | 36 | $1,602 | $45 |
| Hydrochlorothiazide | 147 | $1,375 | $9 |
| Metolazone | 16 | $1,361 | $85 |
| Hydralazine | 69 | $1,349 | $20 |
| Amlodipine Besylate | 175 | $1,333 | $8 |
| Potassium Chloride | 37 | $1,206 | $33 |
| Lisinopril | 144 | $1,129 | $8 |
| Carvedilol | 88 | $1,115 | $13 |
| Valsartan | 11 | $1,087 | $99 |
| Pravastatin | 40 | $1,060 | $27 |
| Cartia Xt | 13 | $863 | $66 |
| Dilt-Xr | 14 | $854 | $61 |
| Warfarin | 49 | $851 | $17 |
| Furosemide | 113 | $739 | $7 |
| Losartan-Hydrochlorothiazide | 36 | $676 | $19 |
| Enalapril Maleate | 17 | $623 | $37 |
| Metoprolol | 83 | $529 | $6 |
| Simvastatin | 67 | $510 | $8 |
| Isosorbide Mononitrate Er | 22 | $375 | $17 |
| Spironolactone | 36 | $371 | $10 |
| Olmesartan Medoxomil | 12 | $268 | $22 |
| Triamterene-Hydrochlorothiazid | 18 | $248 | $14 |
| Clonidine | 13 | $241 | $19 |
| Atenolol | 15 | $224 | $15 |
| Benazepril | 12 | $182 | $15 |
2019: 43 drugs
| Eliquis | 245 | $204,057 | $833 |
| Xarelto | 65 | $72,693 | $1,118 |
| Bystolic | 113 | $34,264 | $303 |
| Entresto | 31 | $23,308 | $752 |
| Brilinta | 34 | $15,733 | $463 |
| Amiodarone | 75 | $11,302 | $151 |
| Rosuvastatin | 191 | $9,950 | $52 |
| Metoprolol | 206 | $5,991 | $29 |
| Ranolazine Er | 11 | $4,258 | $387 |
| Clopidogrel | 208 | $3,882 | $19 |
| Atorvastatin | 194 | $3,479 | $18 |
| Sildenafil Citrate | 21 | $3,436 | $164 |
| Digoxin | 61 | $2,895 | $47 |
| Losartan | 196 | $2,463 | $13 |
| Ezetimibe | 32 | $2,437 | $76 |
| Nifedipine Er | 30 | $2,407 | $80 |
| Amlodipine Besylate | 203 | $2,361 | $12 |
| Sotalol | 58 | $2,202 | $38 |
| Propafenone | 26 | $2,053 | $79 |
| Lisinopril | 169 | $1,649 | $10 |
| Pravastatin | 55 | $1,609 | $29 |
| Diltiazem 24hr Er (Cd) | 43 | $1,567 | $36 |
| Bumetanide | 25 | $1,553 | $62 |
| Potassium Chloride | 41 | $1,323 | $32 |
| Digitek | 13 | $1,228 | $94 |
| Enalapril Maleate | 26 | $1,150 | $44 |
| Dilt-Xr | 15 | $1,149 | $77 |
| Digox | 18 | $1,058 | $59 |
| Furosemide | 126 | $1,038 | $8 |
| Carvedilol | 81 | $1,010 | $12 |
| Warfarin | 54 | $982 | $18 |
| Hydrochlorothiazide | 103 | $967 | $9 |
| Cartia Xt | 19 | $908 | $48 |
| Toprol Xl | 12 | $850 | $71 |
| Losartan-Hydrochlorothiazide | 49 | $761 | $16 |
| Metoprolol | 92 | $692 | $8 |
| Simvastatin | 67 | $627 | $9 |
| Spironolactone | 54 | $614 | $11 |
| Hydralazine | 27 | $481 | $18 |
| Triamterene-Hydrochlorothiazid | 24 | $348 | $14 |
| Isosorbide Mononitrate Er | 14 | $342 | $24 |
| Atenolol | 22 | $338 | $15 |
| Lisinopril-Hydrochlorothiazide | 12 | $94 | $8 |
2018: 49 drugs
| Eliquis | 220 | $177,580 | $807 |
| Tracleer | 12 | $141,042 | $11,753 |
| Letairis | 12 | $114,091 | $9,508 |
| Xarelto | 58 | $58,639 | $1,011 |
| Bystolic | 104 | $29,194 | $281 |
| Entresto | 28 | $24,683 | $882 |
| Brilinta | 31 | $14,712 | $475 |
| Rosuvastatin | 192 | $10,634 | $55 |
| Amiodarone | 69 | $9,400 | $136 |
| Effient | 14 | $6,571 | $469 |
| Metoprolol | 185 | $5,454 | $29 |
| Clopidogrel | 276 | $5,143 | $19 |
| Sildenafil | 35 | $4,756 | $136 |
| Digoxin | 76 | $4,193 | $55 |
| Atorvastatin | 179 | $3,649 | $20 |
| Propafenone | 41 | $3,161 | $77 |
| Nifedipine Er | 32 | $2,725 | $85 |
| Ezetimibe | 22 | $2,592 | $118 |
| Pravastatin | 60 | $2,457 | $41 |
| Losartan | 188 | $2,107 | $11 |
| Amlodipine Besylate | 189 | $2,017 | $11 |
| Potassium Chloride | 44 | $1,856 | $42 |
| Sotalol | 59 | $1,843 | $31 |
| Digitek | 14 | $1,531 | $109 |
| Niacin Er | 14 | $1,460 | $104 |
| Digox | 19 | $1,375 | $72 |
| Lisinopril | 148 | $1,216 | $8 |
| Warfarin | 55 | $1,129 | $21 |
| Bumetanide | 28 | $1,098 | $39 |
| Toprol Xl | 13 | $1,081 | $83 |
| Carvedilol | 96 | $1,020 | $11 |
| Cartia Xt | 26 | $1,001 | $39 |
| Hydrochlorothiazide | 98 | $855 | $9 |
| Furosemide | 124 | $795 | $6 |
| Diltiazem 24hr Er (Cd) | 31 | $785 | $25 |
| Losartan-Hydrochlorothiazide | 58 | $760 | $13 |
| Metoprolol | 100 | $747 | $7 |
| Flecainide Acetate | 12 | $737 | $61 |
| Spironolactone | 49 | $647 | $13 |
| Enalapril Maleate | 11 | $646 | $59 |
| Simvastatin | 80 | $611 | $8 |
| Dilt-Xr | 12 | $601 | $50 |
| Isosorbide Mononitrate Er | 29 | $567 | $20 |
| Levothyroxine | 16 | $565 | $35 |
| Atenolol | 27 | $375 | $14 |
| Triamterene-Hydrochlorothiazid | 17 | $322 | $19 |
| Hydralazine | 16 | $245 | $15 |
| Clonidine | 12 | $150 | $13 |
| Lovastatin | 11 | $60 | $5 |
2017: 56 drugs
| Eliquis | 229 | $145,415 | $635 |
| Tracleer | 13 | $141,747 | $10,904 |
| Letairis | 13 | $119,776 | $9,214 |
| Xarelto | 39 | $30,647 | $786 |
| Bystolic | 74 | $16,955 | $229 |
| Ranexa | 16 | $16,190 | $1,012 |
| Effient | 22 | $11,086 | $504 |
| Amiodarone | 84 | $9,685 | $115 |
| Rosuvastatin | 117 | $8,983 | $77 |
| Brilinta | 12 | $8,936 | $745 |
| Crestor | 16 | $6,827 | $427 |
| Metoprolol | 166 | $5,523 | $33 |
| Clopidogrel | 335 | $5,234 | $16 |
| Digoxin | 87 | $5,090 | $59 |
| Ezetimibe | 11 | $4,435 | $403 |
| Atorvastatin | 167 | $3,247 | $19 |
| Propafenone | 40 | $3,151 | $79 |
| Digox | 32 | $2,771 | $87 |
| Pravastatin | 82 | $2,742 | $33 |
| Sildenafil | 27 | $2,420 | $90 |
| Warfarin | 124 | $1,876 | $15 |
| Potassium Chloride | 48 | $1,874 | $39 |
| Amlodipine Besylate | 206 | $1,641 | $8 |
| Digitek | 14 | $1,470 | $105 |
| Losartan | 145 | $1,338 | $9 |
| Amlodipine-Olmesartan | 13 | $1,334 | $103 |
| Enalapril Maleate | 24 | $1,309 | $55 |
| Fenofibrate | 12 | $1,265 | $105 |
| Cartia Xt | 43 | $1,242 | $29 |
| Lisinopril | 165 | $1,204 | $7 |
| Sotalol | 58 | $1,203 | $21 |
| Nifedipine Er | 23 | $1,107 | $48 |
| Carvedilol | 106 | $1,078 | $10 |
| Flecainide Acetate | 17 | $1,056 | $62 |
| Bumetanide | 25 | $1,037 | $41 |
| Isosorbide Mononitrate Er | 54 | $859 | $16 |
| Levothyroxine | 22 | $842 | $38 |
| Hydrochlorothiazide | 110 | $840 | $8 |
| Metoprolol | 125 | $758 | $6 |
| Valsartan | 23 | $658 | $29 |
| Diltiazem 24hr Er | 15 | $614 | $41 |
| Furosemide | 113 | $599 | $5 |
| Simvastatin | 75 | $582 | $8 |
| Losartan-Hydrochlorothiazide | 50 | $529 | $11 |
| Labetalol | 13 | $479 | $37 |
| Spironolactone | 38 | $438 | $12 |
| Triamterene-Hydrochlorothiazid | 24 | $358 | $15 |
| Dilt-Xr | 14 | $328 | $23 |
| Hydralazine | 15 | $316 | $21 |
| Pantoprazole | 24 | $278 | $12 |
| Valsartan-Hydrochlorothiazide | 11 | $263 | $24 |
| Nitroglycerin Patch | 11 | $244 | $22 |
| Atenolol | 26 | $219 | $8 |
| Benazepril | 15 | $138 | $9 |
| Jantoven | 19 | $133 | $7 |
| Lovastatin | 12 | $85 | $7 |
2016: 57 drugs
| Tracleer | 25 | $232,104 | $9,284 |
| Eliquis | 184 | $108,794 | $591 |
| Crestor | 64 | $33,010 | $516 |
| Bystolic | 115 | $24,737 | $215 |
| Xarelto | 31 | $18,515 | $597 |
| Effient | 22 | $13,939 | $634 |
| Ranexa | 15 | $11,316 | $754 |
| Brilinta | 18 | $9,610 | $534 |
| Zetia | 14 | $7,956 | $568 |
| Vytorin | 14 | $7,772 | $555 |
| Amiodarone | 70 | $7,011 | $100 |
| Clopidogrel | 348 | $6,685 | $19 |
| Rosuvastatin | 26 | $5,600 | $215 |
| Atorvastatin | 184 | $4,856 | $26 |
| Metoprolol | 131 | $4,672 | $36 |
| Coreg Cr | 12 | $3,810 | $317 |
| Digoxin | 89 | $3,694 | $42 |
| Azor | 12 | $3,043 | $254 |
| Pravastatin | 76 | $2,351 | $31 |
| Digox | 35 | $1,995 | $57 |
| Potassium Chloride | 45 | $1,804 | $40 |
| Sildenafil | 22 | $1,801 | $82 |
| Propafenone | 42 | $1,746 | $42 |
| Amlodipine Besylate | 169 | $1,711 | $10 |
| Warfarin | 123 | $1,586 | $13 |
| Losartan | 97 | $1,331 | $14 |
| Lisinopril | 130 | $1,248 | $10 |
| Niacin Er | 12 | $1,209 | $101 |
| Carvedilol | 106 | $1,177 | $11 |
| Valsartan | 22 | $1,091 | $50 |
| Enalapril Maleate | 30 | $1,080 | $36 |
| Sotalol | 39 | $934 | $24 |
| Flecainide Acetate | 15 | $914 | $61 |
| Isosorbide Mononitrate Er | 47 | $822 | $17 |
| Hydrochlorothiazide | 105 | $799 | $8 |
| Simvastatin | 71 | $796 | $11 |
| Nifedipine Er | 11 | $774 | $70 |
| Levothyroxine | 19 | $726 | $38 |
| Metoprolol | 94 | $680 | $7 |
| Diltiazem 24hr Er | 18 | $665 | $37 |
| Bumetanide | 24 | $608 | $25 |
| Irbesartan | 12 | $541 | $45 |
| Cartia Xt | 16 | $533 | $33 |
| Losartan-Hydrochlorothiazide | 35 | $484 | $14 |
| Quinapril | 11 | $467 | $42 |
| Pantoprazole | 23 | $440 | $19 |
| Propranolol | 15 | $436 | $29 |
| Nifedical Xl | 11 | $428 | $39 |
| Furosemide | 96 | $402 | $4 |
| Spironolactone | 26 | $388 | $15 |
| Triamterene-Hydrochlorothiazid | 26 | $319 | $12 |
| Nitroglycerin Patch | 12 | $272 | $23 |
| Allopurinol | 11 | $194 | $18 |
| Jantoven | 17 | $170 | $10 |
| Alprazolam | 12 | $102 | $9 |
| Atenolol | 18 | $96 | $5 |
| Lovastatin | 11 | $80 | $7 |
2015: 50 drugs
| Tracleer | 23 | $195,365 | $8,494 |
| Eliquis | 67 | $46,022 | $687 |
| Crestor | 80 | $29,665 | $371 |
| Bystolic | 107 | $22,515 | $210 |
| Xarelto | 25 | $15,227 | $609 |
| Effient | 22 | $11,935 | $542 |
| Zetia | 20 | $8,524 | $426 |
| Benicar Hct | 15 | $6,451 | $430 |
| Ranexa | 11 | $6,012 | $547 |
| Coreg Cr | 20 | $5,981 | $299 |
| Clopidogrel | 347 | $5,263 | $15 |
| Digoxin | 69 | $4,407 | $64 |
| Azor | 12 | $3,955 | $330 |
| Atorvastatin | 176 | $3,900 | $22 |
| Benicar | 11 | $3,782 | $344 |
| Valsartan | 22 | $3,215 | $146 |
| Pravastatin | 79 | $3,096 | $39 |
| Metoprolol | 72 | $3,096 | $43 |
| Amiodarone | 46 | $2,611 | $57 |
| Potassium Chloride | 38 | $2,609 | $69 |
| Propafenone | 30 | $2,173 | $72 |
| Warfarin | 135 | $2,120 | $16 |
| Digox | 34 | $2,022 | $59 |
| Amlodipine Besylate | 204 | $1,675 | $8 |
| Losartan | 72 | $1,457 | $20 |
| Sildenafil | 15 | $1,292 | $86 |
| Diltiazem 24hr Er | 15 | $1,206 | $80 |
| Hydrochlorothiazide | 116 | $1,041 | $9 |
| Metoprolol | 104 | $886 | $9 |
| Lisinopril | 134 | $885 | $7 |
| Carvedilol | 98 | $851 | $9 |
| Sotalol | 45 | $772 | $17 |
| Simvastatin | 78 | $754 | $10 |
| Quinapril | 21 | $751 | $36 |
| Flecainide Acetate | 15 | $721 | $48 |
| Levothyroxine | 27 | $680 | $25 |
| Cartia Xt | 17 | $652 | $38 |
| Isosorbide Mononitrate Er | 31 | $649 | $21 |
| Losartan-Hydrochlorothiazide | 36 | $547 | $15 |
| Furosemide | 80 | $420 | $5 |
| Irbesartan | 13 | $382 | $29 |
| Pantoprazole | 12 | $365 | $30 |
| Nitroglycerin Patch | 13 | $348 | $27 |
| Enalapril Maleate | 12 | $340 | $28 |
| Spironolactone | 30 | $306 | $10 |
| Triamterene-Hydrochlorothiazid | 25 | $263 | $11 |
| Cilostazol | 11 | $235 | $21 |
| Alprazolam | 13 | $167 | $13 |
| Atenolol | 19 | $120 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $75 | $7 |
2014: 51 drugs
| Tracleer | 16 | $123,223 | $7,701 |
| Eliquis | 40 | $21,664 | $542 |
| Crestor | 59 | $20,639 | $350 |
| Bystolic | 115 | $20,371 | $177 |
| Effient | 24 | $10,476 | $436 |
| Xarelto | 26 | $9,192 | $354 |
| Clopidogrel | 376 | $8,813 | $23 |
| Ranexa | 21 | $8,271 | $394 |
| Coreg Cr | 32 | $7,467 | $233 |
| Benicar | 20 | $5,597 | $280 |
| Vytorin | 13 | $5,015 | $386 |
| Benicar Hct | 21 | $4,801 | $229 |
| Atorvastatin | 172 | $4,606 | $27 |
| Digox | 78 | $4,590 | $59 |
| Diovan | 19 | $4,011 | $211 |
| Zetia | 14 | $3,820 | $273 |
| Propafenone | 49 | $3,762 | $77 |
| Metoprolol | 74 | $3,723 | $50 |
| Pravastatin | 108 | $3,625 | $34 |
| Digoxin | 45 | $3,528 | $78 |
| Potassium Chloride | 45 | $3,315 | $74 |
| Diltiazem 24hr Cd | 14 | $2,518 | $180 |
| Losartan | 81 | $2,467 | $30 |
| Warfarin | 168 | $2,241 | $13 |
| Amlodipine Besylate | 199 | $2,070 | $10 |
| Carvedilol | 107 | $1,444 | $13 |
| Sotalol | 55 | $1,439 | $26 |
| Isosorbide Mononitrate Er | 49 | $1,333 | $27 |
| Diltiazem 24hr Er | 23 | $1,249 | $54 |
| Simvastatin | 99 | $1,206 | $12 |
| Hydrochlorothiazide | 103 | $1,164 | $11 |
| Diltiazem Er | 21 | $1,145 | $55 |
| Lisinopril | 125 | $1,138 | $9 |
| Levothyroxine | 39 | $805 | $21 |
| Irbesartan | 21 | $791 | $38 |
| Metoprolol | 94 | $771 | $8 |
| Amiodarone | 31 | $764 | $25 |
| Valsartan-Hydrochlorothiazide | 13 | $699 | $54 |
| Quinapril | 22 | $676 | $31 |
| Losartan-Hydrochlorothiazide | 35 | $573 | $16 |
| Bumetanide | 21 | $517 | $25 |
| Pantoprazole | 18 | $477 | $26 |
| Furosemide | 72 | $449 | $6 |
| Klor-Con 10 | 17 | $415 | $24 |
| Triamterene-Hydrochlorothiazid | 24 | $303 | $13 |
| Atenolol | 39 | $300 | $8 |
| Nitroglycerin Patch | 11 | $273 | $25 |
| Spironolactone | 19 | $267 | $14 |
| Lovastatin | 13 | $197 | $15 |
| Enalapril Maleate | 13 | $181 | $14 |
| Alprazolam | 14 | $81 | $6 |
2013: 53 drugs
| Tracleer | 15 | $102,292 | $6,819 |
| Crestor | 75 | $23,701 | $316 |
| Clopidogrel | 392 | $22,319 | $57 |
| Bystolic | 115 | $17,432 | $152 |
| Propafenone | 65 | $9,504 | $146 |
| Effient | 29 | $8,457 | $292 |
| Ranexa | 21 | $8,179 | $389 |
| Vytorin | 16 | $7,210 | $451 |
| Diovan | 33 | $5,878 | $178 |
| Atorvastatin | 124 | $5,299 | $43 |
| Coreg Cr | 21 | $5,030 | $240 |
| Benicar | 28 | $4,775 | $171 |
| Diltiazem 24hr Er | 32 | $4,516 | $141 |
| Isosorbide Mononitrate Er | 105 | $3,544 | $34 |
| Losartan | 116 | $3,207 | $28 |
| Metoprolol | 64 | $3,116 | $49 |
| Pravastatin | 121 | $2,599 | $21 |
| Benicar Hct | 17 | $2,485 | $146 |
| Warfarin | 168 | $2,385 | $14 |
| Carvedilol | 159 | $2,367 | $15 |
| Amlodipine Besylate | 183 | $2,295 | $13 |
| Zetia | 13 | $2,155 | $166 |
| Valsartan-Hydrochlorothiazide | 11 | $2,004 | $182 |
| Potassium Chloride | 34 | $1,804 | $53 |
| Diltiazem 24hr Cd | 15 | $1,552 | $103 |
| Simvastatin | 113 | $1,471 | $13 |
| Cartia Xt | 22 | $1,419 | $64 |
| Sotalol | 57 | $1,393 | $24 |
| Digox | 117 | $1,252 | $11 |
| Diltiazem Er | 25 | $1,233 | $49 |
| Lisinopril | 106 | $1,084 | $10 |
| Hydrochlorothiazide | 75 | $907 | $12 |
| Metoprolol | 84 | $799 | $10 |
| Quinapril | 21 | $744 | $35 |
| Klor-Con 10 | 18 | $735 | $41 |
| Pantoprazole | 13 | $564 | $43 |
| Furosemide | 84 | $522 | $6 |
| Losartan-Hydrochlorothiazide | 33 | $486 | $15 |
| Ramipril | 13 | $469 | $36 |
| Atenolol | 46 | $399 | $9 |
| Spironolactone | 31 | $389 | $13 |
| Digoxin | 34 | $387 | $11 |
| Triamterene-Hctz | 25 | $386 | $15 |
| Levothyroxine | 31 | $381 | $12 |
| Klor-Con 8 | 15 | $360 | $24 |
| Bumetanide | 20 | $308 | $15 |
| Nitrostat | 16 | $306 | $19 |
| Nitroglycerin Patch | 12 | $266 | $22 |
| Amiodarone | 20 | $206 | $10 |
| Terazosin | 19 | $195 | $10 |
| Enalapril Maleate | 12 | $135 | $11 |
| Zolpidem | 21 | $120 | $6 |
| Alprazolam | 11 | $68 | $6 |
Money from drug and device companies
$1,245 in 2025
| 2025 | 12 | 52 | None | $1,245 |
| 2024 | 20 | 67 | None | $3,538 |
| 2023 | 16 | 51 | None | $1,148 |
| 2022 | 9 | 22 | None | $1,384 |
| 2021 | 7 | 29 | None | $1,657 |
| 2020 | 8 | 12 | None | $275 |
| 2019 | 17 | 49 | None | $1,134 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Eliquis | $246 | 15 payments
|
| Pfizer | Eliquis | $243 | 12 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $221 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $116 | 4 payments
|
| Actelion Pharmaceuticals US | Opsumit | $86 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $67 | 4 payments
|
See all 52 published payments
| Pfizer | Meals · 2025-12-04 | Eliquis | $11 |
| Pfizer | Meals · 2025-11-24 | Eliquis | $25 |
| Amgen | Meals · 2025-11-19 | Repatha | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Eliquis | $29 |
| Novartis Pharmaceuticals | Meals · 2025-11-05 | Leqvio | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-27 | Eliquis | $14 |
| Actelion Pharmaceuticals US | Meals · 2025-10-15 | Opsynvi | $27 |
| Pfizer | Meals · 2025-10-14 | Eliquis | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-02 | Kerendia | $15 |
| Abbott Laboratories | Meals · 2025-10-02 | Mitraclip | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-01 | Leqvio | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-26 | Eliquis | $12 |
| Philips North America | Meals · 2025-09-24 | Coronary Other | $42 |
| Abbott Laboratories | Meals · 2025-09-24 | Assurity | $37 |
| Actelion Pharmaceuticals US | Meals · 2025-09-12 | Opsumit | $26 |
| Pfizer | Meals · 2025-08-30 | Eliquis | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-29 | Kerendia | $16 |
| Bayer Healthcare Pharmaceuticals | Education · 2025-08-28 | Kerendia | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-15 | Eliquis | $29 |
| Novartis Pharmaceuticals | Meals · 2025-08-11 | Leqvio | $27 |
| Novo Nordisk | Meals · 2025-08-06 | Wegovy | $14 |
| Medtronic | Meals · 2025-08-06 | Mycarelink | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-28 | Eliquis | $13 |
| Pfizer | Meals · 2025-07-18 | Eliquis | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-17 | Kerendia | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-08 | Eliquis | $11 |
| Philips North America | Meals · 2025-07-07 | Specialty Tempus Ic Monitor | $21 |
| Pfizer | Meals · 2025-06-27 | Eliquis | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-16 | Camzyos | $12 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-30 | Camzyos | $13 |
| Shockwave Medical | Meals · 2025-05-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $163 |
| Medtronic | Meals · 2025-05-27 | Corevalve Evolut R | $25 |
| Pfizer | Meals · 2025-05-16 | Eliquis | $8 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-08 | Camzyos | $24 |
| Novo Nordisk | Meals · 2025-05-02 | Wegovy | $24 |
| Pfizer | Meals · 2025-04-29 | Eliquis | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-17 | Eliquis | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-10 | Eliquis | $14 |
| Shockwave Medical | Meals · 2025-04-08 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $45 |
| Pfizer | Meals · 2025-03-29 | Eliquis | $25 |
| Pfizer | Meals · 2025-03-16 | Eliquis | $8 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-13 | Camzyos | $9 |
| Shockwave Medical | Meals · 2025-03-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $12 |
| Amgen | Meals · 2025-03-05 | Repatha | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-13 | Camzyos | $10 |
| Pfizer | Meals · 2025-02-08 | Eliquis | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-30 | Camzyos | $29 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Leqvio | $32 |
| Esperion Therapeutics | Meals · 2025-01-23 | Nexletol | $24 |
| Pfizer | Meals · 2025-01-18 | Eliquis | $29 |
| Actelion Pharmaceuticals US | Meals · 2025-01-15 | Opsumit | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-09 | Camzyos | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,538
| Medtronic | Corevalve Evolut R | $2,224 | 22 payments
|
| Pfizer | Eliquis | $209 | 11 payments
|
| Actelion Pharmaceuticals US | Opsumit | $188 | 6 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $155 | 2 payments
|
| Novo Nordisk | None | $119 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $94 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $88 | 3 payments
|
| Amgen | Repatha | $60 | 3 payments
|
| Philips North America | (Br0) Coronary Atherectomy | $52 | 1 payment
|
| Teleflex | Guideliner | $48 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $46 | 2 payments
|
| Abiomed | Impella | $43 | 1 payment
|
| Esperion Therapeutics | Nexletol | $42 | 2 payments
|
| Boston Scientific | Watchman Flx | $37 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $30 | 1 payment
|
| Getinge USA Sales | Cardiosave Hybrid, Type B Plug | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $16 | 1 payment
|
| Terumo Medical | Angio-Seal | $15 | 1 payment
|
2023: $1,148
| Pfizer | Eliquis | $203 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $191 | 13 payments
|
| Philips Electronics North America | (6571) Eagle Eye | $161 | 4 payments
|
| Actelion Pharmaceuticals US | Opsumit | $134 | 3 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $107 | 5 payments
|
| Merck Sharp & Dohme | Verquvo | $105 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $35 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $34 | 1 payment
|
| Penumbra | Indigo System | $33 | 1 payment
|
| Boston Scientific | Watchman Flx | $32 | 2 payments
|
| Amgen | Repatha | $27 | 1 payment
|
| Abbott Laboratories | Jot Dx | $26 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $20 | 1 payment
|
| Biotronik | Solia | $20 | 1 payment
|
| Asahi Intecc USA | Asahi Ptca Guide Wire | $14 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $4 | 1 payment
|
2022: $1,384
| Medtronic | Corevalve Evolut R | $1,028 | 9 payments
|
| Philips Electronics North America | (5027) Intact Vascular Und | $159 | 4 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $57 | 1 payment
|
| Terumo Medical | Glidewire | $43 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $26 | 2 payments
|
| Pfizer | Eliquis | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $16 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $12 | 1 payment
|
2021: $1,657
| Medtronic | Corevalve Evolut | $1,290 | 13 payments
|
| Philips Electronics North America | (8333) Igt D Coronary | $207 | 7 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $73 | 5 payments
|
| Actelion Pharmaceuticals US | Opsumit | $30 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $21 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
2020: $275
| Philips Electronics North America | Igt D Coronary | $150 | 4 payments
|
| Abbott Laboratories | Confirm Rx | $38 | 2 payments
|
| Medtronic Vascular | Resolute | $18 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $16 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $15 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $14 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $12 | 1 payment
|
| Boston Scientific | Opticross | $12 | 1 payment
|
2019: $1,134
| Philips Electronics North America | Igt D Coronary | $176 | 2 payments
|
| Medtronic Vascular | 3f | $123 | 1 payment
|
| Pfizer | Eliquis | $114 | 7 payments
|
| Actelion Pharmaceuticals US | Opsumit | $114 | 8 payments
|
| Janssen Pharmaceuticals | Xarelto | $103 | 5 payments
|
| Akcea Therapeutics | Tegsedi | $98 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $71 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $64 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $61 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $49 | 3 payments
|
| Abbott Laboratories | Mitra Clip System | $37 | 2 payments
|
| Portola Pharmaceuticals | Andexxa | $35 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $27 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $22 | 1 payment
|
| Gilead Sciences | None | $20 | 1 payment
|
| Biotronik | None | $17 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $5 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 738 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 96%That's most of the people this applied to. | 450 |
| Coronary Artery Disease (CAD): Antiplatelet TherapyAs Medicare defines this measure | 100% | 250 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 8%That's few of the people this applied to. Better on this measure. | 89 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 2,050 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 860 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1629056692
- Licence
- CA G83930California G83930: Current · expires 2028-10-31
- Trained
- Medical College of Wisconsin, 1994 · 32 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2030 Forest Ave, Suite 210, San Jose, CA, 95128
- NPI first listed
- 2006-01-09
- NPI last updated
- 2012-02-27
This is when the NPI record was last certified, not a medical board exam.